To include your compound in the COVID-19 Resource Center, submit it here.

Rhopressa: Phase III started

Aerie began the double-blind, Canadian Phase III Rocket 3 trial to compare once-

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE